BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 36914548)

  • 1. Specific activation of cGAS-STING pathway by nanotherapeutics-mediated ferroptosis evoked endogenous signaling for boosting systemic tumor immunotherapy.
    Liang JL; Jin XK; Zhang SM; Huang QX; Ji P; Deng XC; Cheng SX; Chen WH; Zhang XZ
    Sci Bull (Beijing); 2023 Mar; 68(6):622-636. PubMed ID: 36914548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decomposable Nanoagonists Enable NIR-Elicited cGAS-STING Activation for Tandem-Amplified Photodynamic-Metalloimmunotherapy.
    Guo X; Tu P; Wang X; Du C; Jiang W; Qiu X; Wang J; Chen L; Chen Y; Ren J
    Adv Mater; 2024 May; 36(21):e2313029. PubMed ID: 38353366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies involving STING pathway activation for cancer immunotherapy: Mechanism and agonists.
    Pan X; Zhang W; Guo H; Wang L; Wu H; Ding L; Yang B
    Biochem Pharmacol; 2023 Jul; 213():115596. PubMed ID: 37201875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering and Delivery of cGAS-STING Immunomodulators for the Immunotherapy of Cancer and Autoimmune Diseases.
    Zhou S; Cheng F; Zhang Y; Su T; Zhu G
    Acc Chem Res; 2023 Nov; 56(21):2933-2943. PubMed ID: 37802125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A General Biomineralization Strategy to Synthesize Autologous Cancer Vaccines with cGAS-STING Activating Capacity for Postsurgical Immunotherapy.
    Li Q; Dong Z; Cao Z; Lei H; Wang C; Hao Y; Feng L; Liu Z
    ACS Nano; 2023 Jun; 17(11):10496-10510. PubMed ID: 37184402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BIBR1532 combined with radiotherapy induces ferroptosis in NSCLC cells and activates cGAS-STING pathway to promote anti-tumor immunity.
    Bao Y; Pan Z; Zhao L; Qiu J; Cheng J; Liu L; Qian D
    J Transl Med; 2024 May; 22(1):519. PubMed ID: 38816831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of micronucleus-activated cGAS-STING signaling in antitumor immunity.
    Shen Q; Xu P; Mei C
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2024 Jan; 53(1):25-34. PubMed ID: 38273467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salmonella Induces the cGAS-STING-Dependent Type I Interferon Response in Murine Macrophages by Triggering mtDNA Release.
    Xu L; Li M; Yang Y; Zhang C; Xie Z; Tang J; Shi Z; Chen S; Li G; Gu Y; Wang X; Zhang F; Wang Y; Shen X
    mBio; 2022 Jun; 13(3):e0363221. PubMed ID: 35604097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. iNOS aggravates pressure overload-induced cardiac dysfunction via activation of the cytosolic-mtDNA-mediated cGAS-STING pathway.
    Guo Y; You Y; Shang FF; Wang X; Huang B; Zhao B; Lv D; Yang S; Xie M; Kong L; Du D; Luo S; Tian X; Xia Y
    Theranostics; 2023; 13(12):4229-4246. PubMed ID: 37554263
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuropeptide substance P attenuates colitis by suppressing inflammation and ferroptosis via the cGAS-STING signaling pathway.
    Lan J; Deng Z; Wang Q; Li D; Fan K; Chang J; Ma Y
    Int J Biol Sci; 2024; 20(7):2507-2531. PubMed ID: 38725846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive elaboration of the cGAS-STING signaling axis in cancer development and immunotherapy.
    Zheng J; Mo J; Zhu T; Zhuo W; Yi Y; Hu S; Yin J; Zhang W; Zhou H; Liu Z
    Mol Cancer; 2020 Aug; 19(1):133. PubMed ID: 32854711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. cGAS/cGAMP/STING signal propagation in the tumor microenvironment: Key role for myeloid cells in antitumor immunity.
    Mekers VE; Kho VM; Ansems M; Adema GJ
    Radiother Oncol; 2022 Sep; 174():158-167. PubMed ID: 35870728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial DNA leakage induces odontoblast inflammation via the cGAS-STING pathway.
    Zhou L; Zhang YF; Yang FH; Mao HQ; Chen Z; Zhang L
    Cell Commun Signal; 2021 May; 19(1):58. PubMed ID: 34016129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cGAS-STING signaling in cardiovascular and metabolic diseases: Future novel target option for pharmacotherapy.
    Oduro PK; Zheng X; Wei J; Yang Y; Wang Y; Zhang H; Liu E; Gao X; Du M; Wang Q
    Acta Pharm Sin B; 2022 Jan; 12(1):50-75. PubMed ID: 35127372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperbaric oxygen facilitates teniposide-induced cGAS-STING activation to enhance the antitumor efficacy of PD-1 antibody in HCC.
    Li K; Gong Y; Qiu D; Tang H; Zhang J; Yuan Z; Huang Y; Qin Y; Ye L; Yang Y
    J Immunother Cancer; 2022 Aug; 10(8):. PubMed ID: 36002188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy.
    Lv M; Chen M; Zhang R; Zhang W; Wang C; Zhang Y; Wei X; Guan Y; Liu J; Feng K; Jing M; Wang X; Liu YC; Mei Q; Han W; Jiang Z
    Cell Res; 2020 Nov; 30(11):966-979. PubMed ID: 32839553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipotoxicity-induced mtDNA release promotes diabetic cardiomyopathy by activating the cGAS-STING pathway in obesity-related diabetes.
    Ma XM; Geng K; Law BY; Wang P; Pu YL; Chen Q; Xu HW; Tan XZ; Jiang ZZ; Xu Y
    Cell Biol Toxicol; 2023 Feb; 39(1):277-299. PubMed ID: 35235096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rocaglamide promotes the infiltration and antitumor immunity of NK cells by activating cGAS-STING signaling in non-small cell lung cancer.
    Yan X; Yao C; Fang C; Han M; Gong C; Hu D; Shen W; Wang L; Li S; Zhu S
    Int J Biol Sci; 2022; 18(2):585-598. PubMed ID: 35002511
    [No Abstract]   [Full Text] [Related]  

  • 19. Activation of the cGAS-STING innate immune response in cells with deficient mitochondrial topoisomerase TOP1MT.
    Al Khatib I; Deng J; Lei Y; Torres-Odio S; Rojas GR; Newman LE; Chung BK; Symes A; Zhang H; Huang SN; Pommier Y; Khan A; Shadel GS; West AP; Gibson WT; Shutt TE
    Hum Mol Genet; 2023 Jul; 32(15):2422-2440. PubMed ID: 37129502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cGAS-STING Pathway: A Ubiquitous Checkpoint Perturbing Myocardial Attributes.
    Wan X; Tian J; Hao P; Zhang J; Zhou Y; Ge C; Song X
    Curr Vasc Pharmacol; 2023; 21(3):152-162. PubMed ID: 37138486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.